Shares of Exantas Capital Corp (NYSE:XAN) have been given an average broker rating score of 2.00 (Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a hold recommendation, one has issued a buy recommendation and one has issued a strong buy recommendation on the company. Exantas Capital’s rating score has declined by 14.3% from 90 days ago as a result of various analysts’ upgrades and downgrades.

Brokers have set a one year consensus price objective of $12.33 for the company and are anticipating that the company will post $0.24 earnings per share for the current quarter, according to Zacks. Zacks has also given Exantas Capital an industry rank of 31 out of 255 based on the ratings given to its competitors.

XAN has been the subject of a number of research analyst reports. Zacks Investment Research cut Exantas Capital from a “hold” rating to a “sell” rating in a research note on Saturday, March 9th. ValuEngine raised Exantas Capital from a “hold” rating to a “buy” rating in a research note on Thursday, February 7th.

NYSE:XAN traded down $0.02 on Monday, reaching $10.69. The company’s stock had a trading volume of 89,400 shares, compared to its average volume of 147,240. Exantas Capital has a 1-year low of $9.40 and a 1-year high of $12.09. The company has a current ratio of 132.44, a quick ratio of 132.44 and a debt-to-equity ratio of 2.81. The stock has a market cap of $341.11 million, a price-to-earnings ratio of 15.06 and a beta of 0.80.

Exantas Capital (NYSE:XAN) last posted its earnings results on Tuesday, March 5th. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01. Exantas Capital had a return on equity of 2.75% and a net margin of 49.61%. The firm had revenue of $15.58 million during the quarter, compared to analysts’ expectations of $14.70 million. Sell-side analysts forecast that Exantas Capital will post 1.01 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be given a dividend of $0.20 per share. This is a boost from Exantas Capital’s previous quarterly dividend of $0.18. This represents a $0.80 annualized dividend and a dividend yield of 7.48%. The ex-dividend date is Thursday, March 28th. Exantas Capital’s dividend payout ratio is currently 112.68%.

Hedge funds have recently bought and sold shares of the company. Quantamental Technologies LLC acquired a new position in shares of Exantas Capital during the fourth quarter worth about $31,000. Legal & General Group Plc boosted its position in shares of Exantas Capital by 28.8% during the fourth quarter. Legal & General Group Plc now owns 6,214 shares of the company’s stock worth $62,000 after buying an additional 1,390 shares during the period. Metropolitan Life Insurance Co. NY boosted its position in shares of Exantas Capital by 260.8% during the fourth quarter. Metropolitan Life Insurance Co. NY now owns 8,465 shares of the company’s stock worth $85,000 after buying an additional 6,119 shares during the period. SG Americas Securities LLC acquired a new position in shares of Exantas Capital during the third quarter worth about $124,000. Finally, Bank of America Corp DE boosted its position in shares of Exantas Capital by 56.3% during the fourth quarter. Bank of America Corp DE now owns 19,606 shares of the company’s stock worth $196,000 after buying an additional 7,065 shares during the period. 66.66% of the stock is owned by institutional investors.

About Exantas Capital

Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments related to commercial real estate (CRE), commercial mortgage-backed securities, and CRE equity investments.

Featured Story: Compound Interest

Get a free copy of the Zacks research report on Exantas Capital (XAN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exantas Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exantas Capital and related companies with MarketBeat.com's FREE daily email newsletter.